Literature DB >> 24982314

Clinical and economic impact of a quality improvement initiative to enhance early recognition and treatment of sepsis.

William R Judd1, Dana M Stephens2, Charles A Kennedy2.   

Abstract

BACKGROUND: Studies evaluating the clinical effectiveness of sepsis screening tools and methods to improve the time from diagnosis to antibiotic administration are needed to improve sepsis-related outcomes.
OBJECTIVE: To evaluate the clinical and economic impact of a sepsis quality improvement initiative to improve early recognition and treatment of sepsis.
METHODS: A retrospective observational study of adults with sepsis was performed in a 433-bed tertiary medical center. Baseline data were collected for 181 patients with sepsis diagnosis-related group (DRG) coding assignments from July through September 2013. The intervnetion group included 216 patients from October through December 2013. A First-Dose STAT Antibiotic policy was developed, and nurses were instructed to complete an electronic sepsis screening tool once per shift. Primary outcomes included in-hospital mortality and intensive care unit (ICU) length of stay (LOS). Secondary outcomes included overall LOS and cost per case.
RESULTS: Nonsignificant decreases in overall LOS (7.43 ± 5.68 days vs 6.77 ± 5 days; P = 0.138) and in-hospital mortality (13.8% vs 8.8%; P = 0.113) were observed in patients with sepsis DRGs. Early recognition and treatment contributed to significant reductions in ICU LOS (5.85 ± 4.38 days vs 4.21 ± 3.64 days; P = 0.003) and total cost per case ($14 378 vs $12 311; P = 0.033). The percentage of highest disease-severity DRG coding assignments decreased from 7.9% to 0%.
CONCLUSIONS: Strategies to improve early recognition and treatment of sepsis, including routine use of an electronic sepsis screening tool and implementation of a First-Dose STAT Antibiotic policy, contributed to significant reductions in ICU LOS and cost per case.
© The Author(s) 2014.

Entities:  

Keywords:  antibiotics; clinical practice guidelines; cost-containment; infectious disease; sepsis

Mesh:

Substances:

Year:  2014        PMID: 24982314     DOI: 10.1177/1060028014541792

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  9 in total

1.  The impact of hospital-acquired infections on the patient-level reimbursement-cost relationship in a DRG-based hospital payment system.

Authors:  Klaus Kaier; Martin Wolkewitz; Philip Hehn; Nico T Mutters; Thomas Heister
Journal:  Int J Health Econ Manag       Date:  2019-06-05

2.  Importance of Pharmacy Involvement in the Treatment of Sepsis.

Authors:  Joseph B Cavanaugh; Jesse B Sullivan; Nicole East; Jessica N Nodzon
Journal:  Hosp Pharm       Date:  2017-03

Review 3.  Factors Underlying Racial Disparities in Sepsis Management.

Authors:  Matthew DiMeglio; John Dubensky; Samuel Schadt; Rashmika Potdar; Krzysztof Laudanski
Journal:  Healthcare (Basel)       Date:  2018-11-19

4.  Use of health economic evaluation in the implementation and improvement science fields-a systematic literature review.

Authors:  Sarah Louise Elin Roberts; Andy Healey; Nick Sevdalis
Journal:  Implement Sci       Date:  2019-07-15       Impact factor: 7.327

5.  Predicted Economic Benefits of a Novel Biomarker for Earlier Sepsis Identification and Treatment: A Counterfactual Analysis.

Authors:  Carly J Paoli; Mark A Reynolds; Courtney Coles; Matthew Gitlin; Elliott Crouser
Journal:  Crit Care Explor       Date:  2019-08-07

Review 6.  Computerized Clinical Decision Support Systems for the Early Detection of Sepsis Among Adult Inpatients: Scoping Review.

Authors:  Khalia Ackermann; Jannah Baker; Malcolm Green; Mary Fullick; Hilal Varinli; Johanna Westbrook; Ling Li
Journal:  J Med Internet Res       Date:  2022-02-23       Impact factor: 7.076

7.  Simple Sample Preparation Method for Direct Microbial Identification and Susceptibility Testing From Positive Blood Cultures.

Authors:  Hong-Wei Pan; Wei Li; Rong-Guo Li; Yong Li; Yi Zhang; En-Hua Sun
Journal:  Front Microbiol       Date:  2018-03-20       Impact factor: 5.640

8.  Streptococcal M1 protein induces hyporesponsiveness and cytokine release from human arteries in a fibrinogen-dependent manner: a translational study.

Authors:  Viveka Björck; Lisa I Påhlman; Johan Törnebrant; Mikael Bodelsson
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-07-24       Impact factor: 2.953

9.  Epidemiology and Costs of Sepsis in the United States-An Analysis Based on Timing of Diagnosis and Severity Level.

Authors:  Carly J Paoli; Mark A Reynolds; Meenal Sinha; Matthew Gitlin; Elliott Crouser
Journal:  Crit Care Med       Date:  2018-12       Impact factor: 7.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.